<DOC>
	<DOCNO>NCT00467935</DOCNO>
	<brief_summary>This trial aim patient advanced wet macular degeneration macular scar treat wiht intravitreal injection Lucentis .</brief_summary>
	<brief_title>Scotoma Reduction AMD Patients Treated With Ranibizumab</brief_title>
	<detailed_description>Patients severe wet macular degeneration scar center retina may benefit treatment size blind spot reduce wiht injection Lucentis .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Scotoma</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>BCVA &lt; 20/320 Disciform macular degeneration wiht exudation Nonamd CNV</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>amd</keyword>
	<keyword>disciform</keyword>
	<keyword>fibrosis</keyword>
	<keyword>Lucentis</keyword>
	<keyword>scotoma</keyword>
</DOC>